
### [MONDO:0002887](http://purl.obolibrary.org/obo/MONDO_0002887)
**Label:** bile duct disease

**Subclasses:** [MONDO:0011156](http://purl.obolibrary.org/obo/MONDO_0011156) (progressive familial intrahepatic cholestasis type 2), [MONDO:0014381](http://purl.obolibrary.org/obo/MONDO_0014381) (cholestasis, progressive familial intrahepatic, 4), [MONDO:0006757](http://purl.obolibrary.org/obo/MONDO_0006757) (extrahepatic cholestasis), [MONDO:0005667](http://purl.obolibrary.org/obo/MONDO_0005667) (biliary dyskinesia), [MONDO:0002155](http://purl.obolibrary.org/obo/MONDO_0002155) (cholecystitis), [MONDO:0000374](http://purl.obolibrary.org/obo/MONDO_0000374) (bile duct carcinoma in situ), [MONDO:0008948](http://purl.obolibrary.org/obo/MONDO_0008948) (cerebrotendinous xanthomatosis), [MONDO:0006633](http://purl.obolibrary.org/obo/MONDO_0006633) (acalculous cholecystitis), [MONDO:0006874](http://purl.obolibrary.org/obo/MONDO_0006874) (obstructive jaundice), [MONDO:0003089](http://purl.obolibrary.org/obo/MONDO_0003089) (bile duct mucoepidermoid carcinoma), [MONDO:0002670](http://purl.obolibrary.org/obo/MONDO_0002670) (ampulla of vater adenocarcinoma), [MONDO:0004451](http://purl.obolibrary.org/obo/MONDO_0004451) (sarcomatous intrahepatic cholangiocarcinoma), [MONDO:0011559](http://purl.obolibrary.org/obo/MONDO_0011559) (benign recurrent intrahepatic cholestasis type 2), [MONDO:0013681](http://purl.obolibrary.org/obo/MONDO_0013681) (alpha-methylacyl-CoA racemase deficiency), [MONDO:0008892](http://purl.obolibrary.org/obo/MONDO_0008892) (progressive familial intrahepatic cholestasis type 1), [MONDO:0004509](http://purl.obolibrary.org/obo/MONDO_0004509) (intrahepatic biliary papillomatosis), [MONDO:0015581](http://purl.obolibrary.org/obo/MONDO_0015581) (bile acid synthesis defect with cholestasis and malabsorption), [MONDO:0009469](http://purl.obolibrary.org/obo/MONDO_0009469) (benign recurrent intrahepatic cholestasis type 1), [MONDO:0004346](http://purl.obolibrary.org/obo/MONDO_0004346) (signet ring cell intrahepatic cholangiocarcinoma), [MONDO:0001751](http://purl.obolibrary.org/obo/MONDO_0001751) (cholestasis), [MONDO:0004465](http://purl.obolibrary.org/obo/MONDO_0004465) (periampullary adenocarcinoma), [MONDO:0003377](http://purl.obolibrary.org/obo/MONDO_0003377) (extrahepatic bile duct leiomyosarcoma), [MONDO:0004462](http://purl.obolibrary.org/obo/MONDO_0004462) (extrahepatic bile duct cystadenoma), [MONDO:0003490](http://purl.obolibrary.org/obo/MONDO_0003490) (ampulla of vater squamous cell carcinoma), [MONDO:0003090](http://purl.obolibrary.org/obo/MONDO_0003090) (extrahepatic bile duct carcinoma), [MONDO:0000919](http://purl.obolibrary.org/obo/MONDO_0000919) (ampulla of vater cancer), [MONDO:0014884](http://purl.obolibrary.org/obo/MONDO_0014884) (cholestasis, progressive familial intrahepatic, 5; PFIC5), [MONDO:0013433](http://purl.obolibrary.org/obo/MONDO_0013433) (primary sclerosing cholangitis), [MONDO:0011497](http://purl.obolibrary.org/obo/MONDO_0011497) (hereditary North american indian childhood cirrhosis), [MONDO:0018841](http://purl.obolibrary.org/obo/MONDO_0018841) (congenital bile acid synthesis defect), [MONDO:0021299](http://purl.obolibrary.org/obo/MONDO_0021299) (carcinoma in situ of extrahepatic bile duct), [MONDO:0007829](http://purl.obolibrary.org/obo/MONDO_0007829) (cholestasis, intrahepatic, of pregnancy, 1), [MONDO:0009339](http://purl.obolibrary.org/obo/MONDO_0009339) (congenital bile acid synthesis defect 2), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), [MONDO:0004315](http://purl.obolibrary.org/obo/MONDO_0004315) (cholangiolocellular carcinoma), [MONDO:0003345](http://purl.obolibrary.org/obo/MONDO_0003345) (hilar cholangiocarcinoma), [MONDO:0003500](http://purl.obolibrary.org/obo/MONDO_0003500) (squamous cell bile duct carcinoma), [MONDO:0004039](http://purl.obolibrary.org/obo/MONDO_0004039) (papillary extrahepatic bile duct adenocarcinoma), [MONDO:0006699](http://purl.obolibrary.org/obo/MONDO_0006699) (choledocholithiasis), [MONDO:0013439](http://purl.obolibrary.org/obo/MONDO_0013439) (congenital bile acid synthesis defect 3), [MONDO:0019008](http://purl.obolibrary.org/obo/MONDO_0019008) (benign recurrent intrahepatic cholestasis), [MONDO:0000921](http://purl.obolibrary.org/obo/MONDO_0000921) (ampulla of vater neoplasm), [MONDO:0021321](http://purl.obolibrary.org/obo/MONDO_0021321) (malignant tumor of extrahepatic bile duct), [MONDO:0002669](http://purl.obolibrary.org/obo/MONDO_0002669) (ampullary signet ring cell adenocarcinoma), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0002665](http://purl.obolibrary.org/obo/MONDO_0002665) (extrahepatic bile duct adenocarcinoma), [MONDO:0000488](http://purl.obolibrary.org/obo/MONDO_0000488) (periampullary adenoma), [MONDO:0006108](http://purl.obolibrary.org/obo/MONDO_0006108) (bile duct adenoma), [MONDO:0002664](http://purl.obolibrary.org/obo/MONDO_0002664) (bile duct signet ring cell carcinoma), [MONDO:0005496](http://purl.obolibrary.org/obo/MONDO_0005496) (bile duct carcinoma), [MONDO:0003193](http://purl.obolibrary.org/obo/MONDO_0003193) (bile duct adenocarcinoma), [MONDO:0011199](http://purl.obolibrary.org/obo/MONDO_0011199) (nephropathy, progressive tubulointerstitial, with cholestatic liver disease), [MONDO:0000978](http://purl.obolibrary.org/obo/MONDO_0000978) (extrahepatic bile duct lipoma), [MONDO:0017290](http://purl.obolibrary.org/obo/MONDO_0017290) (familial intrahepatic cholestasis), [MONDO:0019072](http://purl.obolibrary.org/obo/MONDO_0019072) (intrahepatic cholestasis), [MONDO:0008867](http://purl.obolibrary.org/obo/MONDO_0008867) (biliary atresia), [MONDO:0003444](http://purl.obolibrary.org/obo/MONDO_0003444) (intrahepatic bile duct adenoma), [MONDO:0003445](http://purl.obolibrary.org/obo/MONDO_0003445) (extrahepatic bile duct adenoma), [MONDO:0005742](http://purl.obolibrary.org/obo/MONDO_0005742) (emphysematous cholecystitis), [MONDO:0003286](http://purl.obolibrary.org/obo/MONDO_0003286) (extrahepatic bile duct leiomyoma), [MONDO:0004250](http://purl.obolibrary.org/obo/MONDO_0004250) (extrahepatic bile duct papillary adenoma), [MONDO:0011874](http://purl.obolibrary.org/obo/MONDO_0011874) (neonatal ichthyosis-sclerosing cholangitis syndrome), [MONDO:0021662](http://purl.obolibrary.org/obo/MONDO_0021662) (bile duct neoplasm), [MONDO:0017165](http://purl.obolibrary.org/obo/MONDO_0017165) (bile acid CoA ligase deficiency and defective amidation), [MONDO:0003979](http://purl.obolibrary.org/obo/MONDO_0003979) (intrahepatic bile duct cystadenoma), [MONDO:0002886](http://purl.obolibrary.org/obo/MONDO_0002886) (common bile duct disease), [MONDO:0004789](http://purl.obolibrary.org/obo/MONDO_0004789) (cholangitis), [MONDO:0003455](http://purl.obolibrary.org/obo/MONDO_0003455) (bile duct papillary neoplasm), [MONDO:0004786](http://purl.obolibrary.org/obo/MONDO_0004786) (chronic cholangitis), [MONDO:0011905](http://purl.obolibrary.org/obo/MONDO_0011905) (familial hypercholanemia), [MONDO:0006203](http://purl.obolibrary.org/obo/MONDO_0006203) (extrahepatic bile duct squamous cell carcinoma), [MONDO:0003059](http://purl.obolibrary.org/obo/MONDO_0003059) (bile duct cancer), [MONDO:0006202](http://purl.obolibrary.org/obo/MONDO_0006202) (extrahepatic bile duct adenosquamous carcinoma), [MONDO:0006322](http://purl.obolibrary.org/obo/MONDO_0006322) (non-neoplastic bile duct disorder), [MONDO:0003210](http://purl.obolibrary.org/obo/MONDO_0003210) (intrahepatic cholangiocarcinoma), [MONDO:0021385](http://purl.obolibrary.org/obo/MONDO_0021385) (tumor of extrahepatic bile duct), [MONDO:0011906](http://purl.obolibrary.org/obo/MONDO_0011906) (congenital bile acid synthesis defect 1), [MONDO:0010939](http://purl.obolibrary.org/obo/MONDO_0010939) (low phospholipid associated cholelithiasis), [MONDO:0018816](http://purl.obolibrary.org/obo/MONDO_0018816) (isolated neonatal sclerosing cholangitis), [MONDO:0018646](http://purl.obolibrary.org/obo/MONDO_0018646) (sclerosing cholangitis (disease)), [MONDO:0015015](http://purl.obolibrary.org/obo/MONDO_0015015) (congenital bile acid synthesis defect 6), [MONDO:0001929](http://purl.obolibrary.org/obo/MONDO_0001929) (ascending cholangitis), [MONDO:0014564](http://purl.obolibrary.org/obo/MONDO_0014564) (congenital bile acid synthesis defect 5), [MONDO:0018647](http://purl.obolibrary.org/obo/MONDO_0018647) (secondary sclerosing cholangitis), [MONDO:0018645](http://purl.obolibrary.org/obo/MONDO_0018645) (IgG4-related sclerosing cholangitis), [MONDO:0002739](http://purl.obolibrary.org/obo/MONDO_0002739) (bile duct mucinous adenocarcinoma), [MONDO:0003707](http://purl.obolibrary.org/obo/MONDO_0003707) (distal biliary tract carcinoma), [MONDO:0001928](http://purl.obolibrary.org/obo/MONDO_0001928) (suppurative cholangitis), [MONDO:0003708](http://purl.obolibrary.org/obo/MONDO_0003708) (extrahepatic bile duct small cell adenocarcinoma), [MONDO:0002736](http://purl.obolibrary.org/obo/MONDO_0002736) (ampulla of vater mucinous adenocarcinoma), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0003549](http://purl.obolibrary.org/obo/MONDO_0003549) (adenosquamous bile duct carcinoma), [MONDO:0002577](http://purl.obolibrary.org/obo/MONDO_0002577) (bile duct rhabdomyosarcoma), [MONDO:0004117](http://purl.obolibrary.org/obo/MONDO_0004117) (ampulla of vater small cell carcinoma), [MONDO:0008967](http://purl.obolibrary.org/obo/MONDO_0008967) (congenital bile acid synthesis defect 4), [MONDO:0004875](http://purl.obolibrary.org/obo/MONDO_0004875) (xanthogranulomatous cholecystitis), [MONDO:0002576](http://purl.obolibrary.org/obo/MONDO_0002576) (embryonal extrahepatic bile duct rhabdomyosarcoma), [MONDO:0003420](http://purl.obolibrary.org/obo/MONDO_0003420) (bile duct cystadenoma), [MONDO:0003388](http://purl.obolibrary.org/obo/MONDO_0003388) (ampulla of vater clear cell adenocarcinoma), [MONDO:0004078](http://purl.obolibrary.org/obo/MONDO_0004078) (mucinous intrahepatic cholangiocarcinoma), [MONDO:0004353](http://purl.obolibrary.org/obo/MONDO_0004353) (extrahepatic biliary papillomatosis), [MONDO:0011214](http://purl.obolibrary.org/obo/MONDO_0011214) (progressive familial intrahepatic cholestasis type 3), [MONDO:0018804](http://purl.obolibrary.org/obo/MONDO_0018804) (MYO5B-related progressive familial intrahepatic cholestasis), [MONDO:0013995](http://purl.obolibrary.org/obo/MONDO_0013995) (cholestasis, intrahepatic, of pregnancy 3), [MONDO:0018805](http://purl.obolibrary.org/obo/MONDO_0018805) (choledochal cyst), [MONDO:0018802](http://purl.obolibrary.org/obo/MONDO_0018802) (progressive familial intrahepatic cholestasis type 5), [MONDO:0018803](http://purl.obolibrary.org/obo/MONDO_0018803) (progressive familial intrahepatic cholestasis type 4), [MONDO:0015762](http://purl.obolibrary.org/obo/MONDO_0015762) (progressive familial intrahepatic cholestasis), [MONDO:0002868](http://purl.obolibrary.org/obo/MONDO_0002868) (bile duct cystadenocarcinoma), [MONDO:0006709](http://purl.obolibrary.org/obo/MONDO_0006709) (common bile duct neoplasm), [MONDO:0001931](http://purl.obolibrary.org/obo/MONDO_0001931) (pericholangitis), [MONDO:0001930](http://purl.obolibrary.org/obo/MONDO_0001930) (acute cholangitis), [MONDO:0002862](http://purl.obolibrary.org/obo/MONDO_0002862) (bile duct sarcoma), [MONDO:0003553](http://purl.obolibrary.org/obo/MONDO_0003553) (ampulla of vater adenosquamous carcinoma), [MONDO:0010913](http://purl.obolibrary.org/obo/MONDO_0010913) (Caroli disease), [MONDO:0004081](http://purl.obolibrary.org/obo/MONDO_0004081) (bile duct clear cell adenocarcinoma), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0046618](http://purl.obolibrary.org/obo/GO_0046618) (drug export), [GO:0033540](http://purl.obolibrary.org/obo/GO_0033540) (fatty acid beta-oxidation using acyl-CoA oxidase), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0005198](http://purl.obolibrary.org/obo/GO_0005198) (structural molecule activity), [GO:0042254](http://purl.obolibrary.org/obo/GO_0042254) (ribosome biogenesis), [GO:0004301](http://purl.obolibrary.org/obo/GO_0004301) (epoxide hydrolase activity), [GO:0070160](http://purl.obolibrary.org/obo/GO_0070160) (occluding junction), [GO:0033539](http://purl.obolibrary.org/obo/GO_0033539) (fatty acid beta-oxidation using acyl-CoA dehydrogenase), [GO:0005504](http://purl.obolibrary.org/obo/GO_0005504) (fatty acid binding), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:2001205](http://purl.obolibrary.org/obo/GO_2001205) (negative regulation of osteoclast development), [GO:0016410](http://purl.obolibrary.org/obo/GO_0016410) (N-acyltransferase activity), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0015562](http://purl.obolibrary.org/obo/GO_0015562) (efflux transmembrane transporter activity), [GO:0000749](http://purl.obolibrary.org/obo/GO_0000749) (response to pheromone involved in conjugation with cellular fusion), [GO:0030140](http://purl.obolibrary.org/obo/GO_0030140) (trans-Golgi network transport vesicle), [GO:0060119](http://purl.obolibrary.org/obo/GO_0060119) (inner ear receptor cell development), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:1903413](http://purl.obolibrary.org/obo/GO_1903413) (cellular response to bile acid), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0006725](http://purl.obolibrary.org/obo/GO_0006725) (cellular aromatic compound metabolic process), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:1990531](http://purl.obolibrary.org/obo/GO_1990531) (Lem3p-Dnf1p complex), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0070830](http://purl.obolibrary.org/obo/GO_0070830) (bicellular tight junction assembly), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0030490](http://purl.obolibrary.org/obo/GO_0030490) (maturation of SSU-rRNA), [GO:0090554](http://purl.obolibrary.org/obo/GO_0090554) (phosphatidylcholine-translocating ATPase activity), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0047963](http://purl.obolibrary.org/obo/GO_0047963) (glycine N-choloyltransferase activity), [GO:0021650](http://purl.obolibrary.org/obo/GO_0021650) (vestibulocochlear nerve formation), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0008207](http://purl.obolibrary.org/obo/GO_0008207) (C21-steroid hormone metabolic process), [GO:0008206](http://purl.obolibrary.org/obo/GO_0008206) (bile acid metabolic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0099131](http://purl.obolibrary.org/obo/GO_0099131) (ATP hydrolysis coupled ion transmembrane transport), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0032782](http://purl.obolibrary.org/obo/GO_0032782) (bile acid secretion), [GO:0032420](http://purl.obolibrary.org/obo/GO_0032420) (stereocilium), [GO:0070867](http://purl.obolibrary.org/obo/GO_0070867) (mating projection tip membrane), [GO:0090559](http://purl.obolibrary.org/obo/GO_0090559) (regulation of membrane permeability), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0015662](http://purl.obolibrary.org/obo/GO_0015662) (ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0047617](http://purl.obolibrary.org/obo/GO_0047617) (acyl-CoA hydrolase activity), [GO:0005740](http://purl.obolibrary.org/obo/GO_0005740) (mitochondrial envelope), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0006707](http://purl.obolibrary.org/obo/GO_0006707) (cholesterol catabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032534](http://purl.obolibrary.org/obo/GO_0032534) (regulation of microvillus assembly), [GO:0071944](http://purl.obolibrary.org/obo/GO_0071944) (cell periphery), [GO:0061772](http://purl.obolibrary.org/obo/GO_0061772) (drug transport across blood-nerve barrier), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0006637](http://purl.obolibrary.org/obo/GO_0006637) (acyl-CoA metabolic process), [GO:0006635](http://purl.obolibrary.org/obo/GO_0006635) (fatty acid beta-oxidation), [GO:0045177](http://purl.obolibrary.org/obo/GO_0045177) (apical part of cell), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0052816](http://purl.obolibrary.org/obo/GO_0052816) (long-chain acyl-CoA hydrolase activity), [GO:0052817](http://purl.obolibrary.org/obo/GO_0052817) (very long chain acyl-CoA hydrolase activity), [GO:0052815](http://purl.obolibrary.org/obo/GO_0052815) (medium-chain acyl-CoA hydrolase activity), [GO:0035754](http://purl.obolibrary.org/obo/GO_0035754) (B cell chemotaxis), [GO:0015126](http://purl.obolibrary.org/obo/GO_0015126) (canalicular bile acid transmembrane transporter activity), [GO:0015247](http://purl.obolibrary.org/obo/GO_0015247) (aminophospholipid transmembrane transporter activity), [GO:2001140](http://purl.obolibrary.org/obo/GO_2001140) (positive regulation of phospholipid transport), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008396](http://purl.obolibrary.org/obo/GO_0008396) (oxysterol 7-alpha-hydroxylase activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:1902884](http://purl.obolibrary.org/obo/GO_1902884) (positive regulation of response to oxidative stress), [GO:0006892](http://purl.obolibrary.org/obo/GO_0006892) (post-Golgi vesicle-mediated transport), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:1901557](http://purl.obolibrary.org/obo/GO_1901557) (response to fenofibrate), [GO:0005324](http://purl.obolibrary.org/obo/GO_0005324) (long-chain fatty acid transporter activity), [GO:0097176](http://purl.obolibrary.org/obo/GO_0097176) (epoxide metabolic process), [GO:0005319](http://purl.obolibrary.org/obo/GO_0005319) (lipid transporter activity), [GO:0015917](http://purl.obolibrary.org/obo/GO_0015917) (aminophospholipid transport), [GO:0061092](http://purl.obolibrary.org/obo/GO_0061092) (positive regulation of phospholipid translocation), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0015914](http://purl.obolibrary.org/obo/GO_0015914) (phospholipid transport), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0015910](http://purl.obolibrary.org/obo/GO_0015910) (peroxisomal long-chain fatty acid import), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0007030](http://purl.obolibrary.org/obo/GO_0007030) (Golgi organization), [GO:0007031](http://purl.obolibrary.org/obo/GO_0007031) (peroxisome organization), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0050892](http://purl.obolibrary.org/obo/GO_0050892) (intestinal absorption), [GO:0006855](http://purl.obolibrary.org/obo/GO_0006855) (drug transmembrane transport), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0016790](http://purl.obolibrary.org/obo/GO_0016790) (thiolester hydrolase activity), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0015462](http://purl.obolibrary.org/obo/GO_0015462) (ATPase-coupled protein transmembrane transporter activity), [GO:0033791](http://purl.obolibrary.org/obo/GO_0033791) (3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0002152](http://purl.obolibrary.org/obo/GO_0002152) (bile acid conjugation), [GO:0047016](http://purl.obolibrary.org/obo/GO_0047016) (cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity), [GO:0005782](http://purl.obolibrary.org/obo/GO_0005782) (peroxisomal matrix), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0005778](http://purl.obolibrary.org/obo/GO_0005778) (peroxisomal membrane), [GO:0006869](http://purl.obolibrary.org/obo/GO_0006869) (lipid transport), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0001618](http://purl.obolibrary.org/obo/GO_0001618) (virus receptor activity), [GO:0032456](http://purl.obolibrary.org/obo/GO_0032456) (endocytic recycling), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0032052](http://purl.obolibrary.org/obo/GO_0032052) (bile acid binding), [GO:0008065](http://purl.obolibrary.org/obo/GO_0008065) (establishment of blood-nerve barrier), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus), [GO:0000462](http://purl.obolibrary.org/obo/GO_0000462) (maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0032040](http://purl.obolibrary.org/obo/GO_0032040) (small-subunit processome), [GO:0008199](http://purl.obolibrary.org/obo/GO_0008199) (ferric iron binding), [GO:0031073](http://purl.obolibrary.org/obo/GO_0031073) (cholesterol 26-hydroxylase activity), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0070673](http://purl.obolibrary.org/obo/GO_0070673) (response to interleukin-18), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0034455](http://purl.obolibrary.org/obo/GO_0034455) (t-UTP complex), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0047568](http://purl.obolibrary.org/obo/GO_0047568) (3-oxo-5-beta-steroid 4-dehydrogenase activity), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0001650](http://purl.obolibrary.org/obo/GO_0001650) (fibrillar center), [GO:0045943](http://purl.obolibrary.org/obo/GO_0045943) (positive regulation of transcription by RNA polymerase I), [GO:0006544](http://purl.obolibrary.org/obo/GO_0006544) (glycine metabolic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0016338](http://purl.obolibrary.org/obo/GO_0016338) (calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0055088](http://purl.obolibrary.org/obo/GO_0055088) (lipid homeostasis), [GO:0004012](http://purl.obolibrary.org/obo/GO_0004012) (phospholipid-translocating ATPase activity), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0004129](http://purl.obolibrary.org/obo/GO_0004129) (cytochrome-c oxidase activity), [GO:0010008](http://purl.obolibrary.org/obo/GO_0010008) (endosome membrane), [GO:0034312](http://purl.obolibrary.org/obo/GO_0034312) (diol biosynthetic process), [GO:0032376](http://purl.obolibrary.org/obo/GO_0032376) (positive regulation of cholesterol transport), [GO:0016226](http://purl.obolibrary.org/obo/GO_0016226) (iron-sulfur cluster assembly), [GO:0019439](http://purl.obolibrary.org/obo/GO_0019439) (aromatic compound catabolic process), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0006364](http://purl.obolibrary.org/obo/GO_0006364) (rRNA processing), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0016290](http://purl.obolibrary.org/obo/GO_0016290) (palmitoyl-CoA hydrolase activity), [GO:0045332](http://purl.obolibrary.org/obo/GO_0045332) (phospholipid translocation), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0030343](http://purl.obolibrary.org/obo/GO_0030343) (vitamin D3 25-hydroxylase activity), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0007586](http://purl.obolibrary.org/obo/GO_0007586) (digestion), [GO:0008559](http://purl.obolibrary.org/obo/GO_0008559) (xenobiotic transmembrane transporting ATPase activity), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0061007](http://purl.obolibrary.org/obo/GO_0061007) (hepaticobiliary system process), [GO:0045216](http://purl.obolibrary.org/obo/GO_0045216) (cell-cell junction organization), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0033961](http://purl.obolibrary.org/obo/GO_0033961) (cis-stilbene-oxide hydrolase activity), [GO:0030573](http://purl.obolibrary.org/obo/GO_0030573) (bile acid catabolic process), [GO:0071847](http://purl.obolibrary.org/obo/GO_0071847) (TNFSF11-mediated signaling pathway), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:1903348](http://purl.obolibrary.org/obo/GO_1903348) (positive regulation of bicellular tight junction assembly), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0008525](http://purl.obolibrary.org/obo/GO_0008525) (phosphatidylcholine transporter activity), [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction), [GO:0005923](http://purl.obolibrary.org/obo/GO_0005923) (bicellular tight junction), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0102991](http://purl.obolibrary.org/obo/GO_0102991) (myristoyl-CoA hydrolase activity), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0030686](http://purl.obolibrary.org/obo/GO_0030686) (90S preribosome), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0015722](http://purl.obolibrary.org/obo/GO_0015722) (canalicular bile acid transport), [GO:0015721](http://purl.obolibrary.org/obo/GO_0015721) (bile acid and bile salt transport), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0042760](http://purl.obolibrary.org/obo/GO_0042760) (very long-chain fatty acid catabolic process), [GO:1901612](http://purl.obolibrary.org/obo/GO_1901612) (cardiolipin binding), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0003995](http://purl.obolibrary.org/obo/GO_0003995) (acyl-CoA dehydrogenase activity), [GO:0003997](http://purl.obolibrary.org/obo/GO_0003997) (acyl-CoA oxidase activity), [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0019530](http://purl.obolibrary.org/obo/GO_0019530) (taurine metabolic process), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0048194](http://purl.obolibrary.org/obo/GO_0048194) (Golgi vesicle budding), [GO:0019534](http://purl.obolibrary.org/obo/GO_0019534) (toxin transmembrane transporter activity), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 56.00%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.57%
- [GO:0046581](http://purl.obolibrary.org/obo/GO_0046581) (intercellular canaliculus) 50.57%
- [GO:0031526](http://purl.obolibrary.org/obo/GO_0031526) (brush border membrane) 50.57%
- [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane) 50.57%
- [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane) 50.57%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 50.57%
- [GO:0005921](http://purl.obolibrary.org/obo/GO_0005921) (gap junction) 50.57%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 50.57%
- [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane) 50.57%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) 50.57%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044429](http://purl.obolibrary.org/obo/GO_0044429) (mitochondrial part) 50.57%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane) 50.57%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044444](http://purl.obolibrary.org/obo/GO_0044444) (cytoplasmic part) and [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 50.57%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 35.92%


